High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor α receptor (etanercept)

Annals of the Rheumatic Diseases

Volumn 61, Issue 1, 2002, Pages 55-58

  Hau, M ^a   Kneitz, C ^a   Tony, H P ^a   Keberle, M ^a   Jahns, R ^a   Jenett, M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETANERCEPT; METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; ECHOGRAPHY; FEMALE; FINGER BLOOD FLOW; HUMAN; MALE; PAIN ASSESSMENT; PANNUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FINGER JOINT; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PAIN MEASUREMENT; PILOT PROJECTS; RECEPTORS, TUMOR NECROSIS FACTOR; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0036145046     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.1.55     Document Type: Article

References (16)

1. Pathogenesis of bone erosions in rheumatoid arthritis
2. Starving the synovium: Angiogenesis and inflammation in rheumatoid arthritis
3. The adhesion molecules of inflammation
4. Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis
5. Anti-cytokine therapy for rheumatoid arthritis
6. The future role of anti-tumor necrosis factor (TNF) products in the treatment of rheumatoid arthritis
7. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
8. Vascular endothelial growth factor in patients with rheumatoid arthritis
9. Evaluation of pannus and vascularisation of metacarpophalangeal and proximal interphalangeal joint in rheumatoid arthritis by high resolution ultrasound (multi-D-array)
10. Biologic agents for treating rheumatoid arthritis: Concepts and progress
11. Can we predict aggressive disease
12. Differential therapy in early and late stages of rheumatoid arthritis
13. NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy
14. Angiogenesis inhibition suppresses collagen arthritis
15. Taxol involution of collagen-induced arthritis: Ultrastructural correlation with the inhibition of synovifis and neovascularisation
16. Decreased angiogenesis and arthritic disease in rabbits treated with an αv/β3 antagonist